The adsorption of small probe molecules (H2O, NH3 and EtOH) and the small model silane Me2Si(OMe)2 on (104) and (110) surfaces of α-MgCl2 have been studied using periodic DFT calculations including a classical correction (of the type f(R)/R6) for dispersion. The results reveal that donors strongly stabilize both crystal surfaces relative to the bulk solid. Moreover, coordination of two donor molecules to the four-coordinate exposed Mg atom of MgCl2 (110) causes this surface to become preferred over MgCl2 (104) surface with only a single donor per exposed Mg. However, coverage also plays an important role. The model silane preferentially adsorbs in bidentate mode on MgCl2 (110), provided that coverage is 0.5 or lower; at full coverage, there is not enough space for such an arrangement, and only a monodentate binding mode is obtained. Such coverage effects should be even more pronounced for the bulkier silanes used as external donors in real MgCl2-supported Ziegler–Natta systems, as tailored experiments seem to confirm.

Peroxisome proliferator-activated receptor γ (PPARγ) has received significant attention as a key regulator of glucose and lipid homeostasis. In this study, we synthesized and tested a library of novel 5-benzylidene-thiazolidin-2,4-dione (BTZD) derivatives bearing a substituent on nitrogen of TZD nucleus (compounds 1a-1k, 2i-10i, 3a, 6a, and 8a-10a). Three compounds (1a, 1i, and 3a) exhibited selectivity towards PPARγ and were found to be weak to moderate partial agonists. Surface Plasmon Resonance (SPR) results demonstrated binding affinity of 1a, 1i and 3a towards PPARγ. Furthermore, docking experiments revealed that BTZDs interact with PPARγ through a distinct binding mode, forming primarily hydrophobic contacts with the ligand-binding pocket (LBD) without direct H-bonding interactions to key residues in H12 that are characteristic of full agonists. In addition, 1a, 1i and 3a significantly improved hyperglycemia and hyperlipidaemia in streptozotocin-nicotinamide (STZ-NA)-induced diabetic rats at a dose of 36 mg/kg/day administered orally for 15 days. Histopathological investigations revealed that microscopic architecture of pancreatic and hepatic cells improved in BTZDs-treated diabetic rats. These findings suggested that 1a, 1i and 3a are very promising pharmacological agents by selectively targeting PPARγ for further development in the clinical treatment of type 2 diabetes mellitus.

The development of PPARα/γ dual or PPARα/γ/δ pan-agonists could represent an efficacious approach for a simultaneous pharmacological intervention on carbohydrate and lipid metabolism. Two series of new phenyldiazenyl fibrate derivatives of GL479, a previously reported PPARα/γ dual agonist, were synthesized and tested. Compound 12a was identified as a PPAR pan-agonist with moderate and balanced activity on the three PPAR isoforms (α, γ, δ). Moreover, docking experiments showed that 12a adopts a different binding mode in PPARγ compared to PPARα or PPARδ, providing a structural basis for further structure-guided design of PPAR pan-agonists. The beneficial effects of 12a were evaluated both in vitro, on the expression of PPAR target key metabolic genes, and ex vivo in two rat tissue inflammatory models. The obtained results allow considering this compound as an interesting lead for the development of a new class of PPAR pan-agonists endowed with an activation profile exploitable for therapy of metabolic syndrome.

Our previous work discovered that combining the appropriate 5'- and N-substitution in adenosine derivatives leads to the highly selective human A adenosine receptor (hAAR) agonists or highly potent dual hAAR agonists and hAAR antagonists. In order to explore novel dual adenosine receptor ligands, a series of N-substituted-5'-pyrazolyl-adenosine and 2-chloro-adenosine derivatives were synthesized and assayed in vitro at all ARs. The N-(±)-endo-norbornyl derivative 12 was the most potent and selective at AAR and effective as an analgesic in formalin test in mice, but none of the 5'-pyrazolyl series compounds showed a dual behavior at hA and hAAR. Molecular modeling studies rationalized the structure-activity relationships and the selectivity profiles of the new series of AAR agonists. Interestingly, an unexpected inverted binding mode of the N-tetrahydrofuranyl derivative 14 was hypothesized to explain its low affinity at AAR.

Imines obtained by condensation of 4-hydroxybenzohydrazide with aliphatic ketones are a rare example of a class of compounds showing a remarkable tendency to crystallize in acentric polar space groups (Pna21 or Cc). In fact, all of the\ud (seven) compounds studied up to now show at least one polar polymorph. In some cases, polymorphism was detected, and a\ud nonpolar centrosymmetric phase was also identified (P21/c or P21/n space group). With the aim to disclose the conditions that\ud can favor the formation of acentric structures in molecular crystals, we report, in this paper, a theoretical analysis (ab initio density functional theory with periodic boundary) of the lattice energy and density of all the packing modes observed in the whole set of imines. The computational analysis has been performed by optimizing each compound in its own experimental packings (actual crystal structures) and also in the packings of the other compounds of the class (virtual structures). The experimental crystallographic data and the theoretical analysis suggest that two conformers, basically differing for the orientation of the phenolic H atom in the plane of the phenyl ring, compete, in solution, for the formation of polar or centrosymmetric packings. The transitions between polar and centrosymmetric polymorphs are of diffusive type, and single crystals are not preserved, while the transitions between different polar polymorphs can be of single-crystal-to-single-crystal type